Third Rock Ventures IV, L.P., Ten Percent Owner at Dianthus Therapeutics, holds 14.73M shares in Tango Therapeutics (Ticker: TNGX), holds 7.02M shares in Maze Therapeutics, Inc. (Ticker: MAZE), holds 3.06M shares in Dianthus Therapeutics (Ticker: DNTH). Most recently, Third Rock Ventures IV, L.P. Sold ― shares of Tango Therapeutics on Sep 09, 2025 for an estimated value of $5.11M.
What is the percentage of profitable transactions made by Third Rock Ventures IV, L.P.?
The percentage of profitable transactions made by Third Rock Ventures IV, L.P. is 88%.
What is the average return per transaction made by Third Rock Ventures IV, L.P.?
The average return per transaction made by Third Rock Ventures IV, L.P. is 24.10%.
What stocks does Third Rock Ventures IV, L.P. hold?
Third Rock Ventures IV, L.P. holds: DNTH, FULC, RVMD, TNGX, MAZE stocks.
What was Third Rock Ventures IV, L.P.’s latest transaction?
Third Rock Ventures IV, L.P. latest transaction was an Informative Sell of $5.11M.
What was Third Rock Ventures IV, L.P.'s most profitable transaction?
Third Rock Ventures IV, L.P.’s most profitable transaction was an Informative Sell of TNGX stock on February 21, 2024. The return on the trade was 78.60%.
What is Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics?
Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.